Limberg flap reconstruction for recurrent pilonidal sinus disease: A single-center U.S. Cohort - Report - MDSpire

Limberg flap reconstruction for recurrent pilonidal sinus disease: A single-center U.S. Cohort

  • By

  • Mustafa Oruc

  • Joshua Sommovilla

  • Salih Karahan

  • Joseph Trunzo

  • Metincan Erkaya

  • Michael Valente

  • Emre Gorgun

  • February 12, 2026

  • 0 min

Share

Outcomes of Limberg Flap Reconstruction for Recurrent Pilonidal Sinus Disease

Overview

This single-center U.S. study evaluated long-term outcomes of Limberg flap reconstruction in 37 patients with recurrent pilonidal sinus disease. The procedure demonstrated durable disease control with no recurrences over a median 4.5-year follow-up and an acceptable 11% postoperative complication rate.

Background

Pilonidal sinus disease (PSD) is a chronic condition often requiring surgical intervention, with recurrence posing a significant challenge. The Limberg flap (LF) reconstruction technique has shown favorable results internationally but lacks extensive long-term data from U.S. centers, especially for recurrent cases. This study aimed to assess the efficacy and safety of LF reconstruction in a U.S. cohort with recurrent PSD. Understanding outcomes in this population is critical to guide surgical management strategies.

Data Highlights

CharacteristicValue
Number of patients37
Male patients76%
Median BMI29.4 kg/m²
Active smokers59%
Multiple previous pilonidal operations52%
Median operative time72 minutes
Same-day discharge92%
Postoperative complication rate11%
Median follow-up duration4.5 years
Recurrence rate0%

Key Findings

  • Limberg flap reconstruction was performed on 37 patients with recurrent PSD, predominantly male with a median BMI of 29.4 kg/m².
  • More than half of the cohort were active smokers and had multiple prior pilonidal surgeries, indicating a complex patient population.
  • The median operative time was 72 minutes, with 92% of patients discharged on the same day without surgical drains.
  • Postoperative complications occurred in 11% of patients, mainly wound dehiscence, reflecting acceptable morbidity.
  • No disease recurrence was observed during a median follow-up period of 4.5 years, demonstrating durable long-term disease control.

Clinical Implications

Limberg flap reconstruction offers a reliable surgical option for patients with recurrent pilonidal sinus disease, even in those with multiple prior surgeries and risk factors such as smoking. The procedure supports early discharge and has a low complication rate, making it suitable for outpatient management. Surgeons should consider LF reconstruction as a durable and effective approach in complex recurrent PSD cases.

Conclusion

This study supports Limberg flap reconstruction as a safe and effective technique for managing recurrent pilonidal sinus disease, achieving excellent long-term outcomes with minimal morbidity in a U.S. patient cohort.

References

  1. Gil LA, Deans KJ, Minneci PC (2023) Management of pilonidal disease: a review
  2. Emile SH, Khan SM, Barsom SH, Wexner SD (2021) Karydakis procedure versus Limberg flap for treatment of pilonidal sinus: an updated meta-analysis
  3. Doll D, Krueger CM, Schrank S, Dettmann H, Petersen S, Duesel W (2007) Timeline of recurrence after primary and secondary pilonidal sinus surgery
  4. Ojo D, Gallo G, Kleijnen J et al (2024) European Society of Coloproctology guidelines for the management of pilonidal disease

Original Source(s)

Related Content